General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 7, 2022
April 11, 2024
764daa65-55f6-4702-b131-6e18ebf48434
Related Documents
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Quality Considerations for Topical Ophthalmic Drug Products
Guidance DocumentDecember 27, 2023Center for Drug Evaluation and Research
Microbiological Quality Considerations in Non-Sterile Drug Manufacturing: Draft Guidance for Industry
Guidance DocumentSeptember 29, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.